注意Gated-VGG具有基于深度学习的功能,用于阿尔茨海默氏症疾病分类.
Deepthi K Moorthy1, P Nagaraj2
1Department of Computer Science and Engineering, Kalasalingam Academy of Research and Education, Srivilliputhur, Tamil Nadu, India.
Neurodegenerative disease management
|September 10, 2025
概括
早期发现阿尔茨海默病 (AD) 是至关重要的. 一个注意力封闭的VGG深度学习模型在从大脑图像中对AD进行分类时获得了96.7%的准确性,显示了早期诊断的希望.
科学领域:
- 神经科学是一个神经科学.
- 医疗成像医学成像
- 人工智能的人工智能
背景情况:
- 阿尔茨海默病 (AD) 是一种主要的神经退行性疾病,导致认知能力下降和痴呆.
- 早期发现AD对于及时干预和管理至关重要.
- 目前的诊断方法需要改进,以便更早,更准确地识别.
研究的目的:
- 开发和评估一种用于准确分类阿尔茨海默病的新型深度学习模型.
- 为了利用先进的图像处理和特征提取技术来改进AD检测.
- 评估注意力门-VGG模型在区分AD患者与对照者的有效性.
主要方法:
- 图像预处理,包括大小调整和中间选.
- 数据增强以增强培训数据集.
- 使用基于鱼优化算法 (WOA) 的ResNet和卷积神经网络 (CNN) 的特征提取.
- 使用拟议的注意力门-VGG深度学习模型进行分类.
主要成果:
- 注意门-VGG模型实现了高分类性能.
- 获得了96.7%的精度,97.8%的灵敏度和96.3%的特异性.
- 在AD分类任务中表现优于传统方法.
结论:
- 注意门-VGG模型显示出作为早期阿尔茨海默病分类工具的巨大潜力.
- 拟议的深度学习方法为改善神经退行性疾病的诊断准确性提供了一个有希望的途径.
- 这种技术可以帮助临床医生更早,更明智地做出关于AD患者护理的决定.
更多相关视频
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
8.4K
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
1.3K
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
827
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
827
Dementia
526
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
526
